Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML Article

Full Text via DOI: 10.1182/blood-2023-178802 Web of Science: 001159306706010

Cited authors

  • Roboz GJ, Finn LE, Orozco JJ, Hegazi M, Desai A, Chen M, Schiller GJ

Publication date

  • 2023

Published in

International Standard Serial Number (ISSN)

  • 0006-4971

Number of pages

  • 4

Volume

  • 142